Callan Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.55M | Buy |
7,408
+1,292
| +21% | +$271K | 0.11% | 85 |
|
|
2024
Q4 | $1.09M | Sell |
6,116
-367
| -6% | -$65.2K | 0.08% | 104 |
|
|
2024
Q3 | $1.28M | Buy |
6,483
+420
| +7% | +$82.9K | 0.09% | 102 |
|
|
2024
Q2 | $1.04M | Buy |
6,063
+66
| +1% | +$11.3K | 0.09% | 107 |
|
|
2024
Q1 | $1.09M | Buy |
5,997
+759
| +14% | +$138K | 0.1% | 96 |
|
|
2023
Q4 | $812K | Sell |
5,238
-577
| -10% | -$89.4K | 0.08% | 105 |
|
|
2023
Q3 | $867K | Buy |
5,815
+1,260
| +28% | +$188K | 0.09% | 86 |
|
|
2023
Q2 | $614K | Buy |
4,555
+607
| +15% | +$81.8K | 0.07% | 98 |
|
|
2023
Q1 | $629K | Sell |
3,948
-1,081
| -21% | -$172K | 0.07% | 96 |
|
|
2022
Q4 | $813K | Buy |
5,029
+2,441
| +94% | +$394K | 0.1% | 88 |
|
|
2022
Q3 | $347K | Buy |
+2,588
| New | +$347K | 0.06% | 97 |
|